{"id":58821,"date":"2026-06-04T22:16:54","date_gmt":"2026-06-04T13:16:54","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4875\/"},"modified":"2026-08-09T14:01:35","modified_gmt":"2026-08-09T05:01:35","slug":"company-4875","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4875\/","title":{"rendered":"MEDICINOVA INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4875","DATE":"2026-01-09","longName":"MediciNova, Inc.","company_name_ja":"","fullTimeEmployees":6,"address":"","phone":"","website":"https:\/\/medicinova.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":233,"financialCurrency":"","marketCap":11451,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-0.23999999999999999,"epsForward":0,"bookValue":0,"totalRevenue":409657,"OperatingIncome":-13283002,"operatingMargins":-3242.4699999999998,"NetIncome":-11997957,"profitMargins":-2928.7800000000002,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-28.850000000000001,"recommendationMean":1.3333299999999999,"recommendationKey":"strong_buy","targetMeanPrice":0,"numberOfAnalystOpinions":4,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:05:07.433090\", \"ticker\": \"4875\", \"ticker_full\": \"4875.T\", \"company_name\": \"MEDICINOVA INC\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 1, \"buy\": 3, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 4, \"recommendation_key\": \"strong_buy\", \"recommendation_mean\": 1.33333}, \"target_prices\": {\"has_data\": true, \"current\": 216.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-13\", \"eps_estimate\": -10.43, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-05-14\", \"eps_estimate\": -10.37, \"eps_actual\": -7.91, \"surprise_pct\": 23.78}, {\"date\": \"2026-02-20\", \"eps_estimate\": -14.53, \"eps_actual\": -7.75, \"surprise_pct\": 46.69}, {\"date\": \"2025-11-12\", \"eps_estimate\": -18.5, \"eps_actual\": -9.29, \"surprise_pct\": 49.8}, {\"date\": \"2025-08-14\", \"eps_estimate\": -17.56, \"eps_actual\": -10.34, \"surprise_pct\": 41.13}, {\"date\": \"2025-05-13\", \"eps_estimate\": -20.57, \"eps_actual\": -8.87, \"surprise_pct\": 56.89}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 2.88, \"institution_pct\": 11.05, \"major_holders\": [{\"label\": \"\", \"value\": 2.88}, {\"label\": \"\", \"value\": 11.05}, {\"label\": \"\", \"value\": 11.38}, {\"label\": \"\", \"value\": 37.0}], \"institutional_holders\": [{\"holder\": \"Essex Woodlands Management Inc.\", \"shares\": 1105941, \"date_reported\": \"2026-03-31\", \"pct_held\": 2.25, \"pct_change\": 0.0, \"value\": 238883256}, {\"holder\": \"Blackrock Inc.\", \"shares\": 705954, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.43, \"pct_change\": 0.14, \"value\": 152486064}, {\"holder\": \"Citigroup Inc.\", \"shares\": 635715, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.29, \"pct_change\": 0.0, \"value\": 137314440}, {\"holder\": \"Vanguard Capital Management LLC\", \"shares\": 611039, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.24, \"pct_change\": 1.0, \"value\": 131984424}, {\"holder\": \"Geode Capital Management, LLC\", \"shares\": 543843, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.1, \"pct_change\": 2.69, \"value\": 117470088}, {\"holder\": \"Vanguard Fiduciary Trust Co\", \"shares\": 280621, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.57, \"pct_change\": 1.0, \"value\": 60614136}, {\"holder\": \"UBS Group AG\", \"shares\": 222200, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.45, \"pct_change\": -1.53, \"value\": 47995200}, {\"holder\": \"Renaissance Technologies, LLC\", \"shares\": 189900, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.39, \"pct_change\": -3.51, \"value\": 41018400}, {\"holder\": \"State Street Corporation\", \"shares\": 193698, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.39, \"pct_change\": 0.0, \"value\": 41838768}, {\"holder\": \"Barclays Plc\", \"shares\": 162900, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.33, \"pct_change\": 3.13, \"value\": 35186400}], \"mutualfund_holders\": [{\"holder\": \"VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund\", \"shares\": 611039, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.24, \"pct_change\": 28.71, \"value\": 131984424}, {\"holder\": \"Fidelity Concord Street Trust-Fidelity Extended Market Index Fund\", \"shares\": 251675, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.51, \"pct_change\": -1.36, \"value\": 54361800}, {\"holder\": \"iShares Trust-iShares Micro-Cap ETF\", \"shares\": 158976, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.32, \"pct_change\": 28.13, \"value\": 34338816}, {\"holder\": \"Fidelity Concord Street Trust-Fidelity Total Market Index Fund\", \"shares\": 87575, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.18, \"pct_change\": 0.0, \"value\": 18916200}, {\"holder\": \"SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund\", \"shares\": 71506, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.15, \"pct_change\": 0.0, \"value\": 15445296}, {\"holder\": \"Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund\", \"shares\": 68406, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.14, \"pct_change\": 0.0, \"value\": 14775696}, {\"holder\": \"Bridgeway Funds, Inc.-Ultra-Small Company Market Fund\", \"shares\": 50247, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.1, \"pct_change\": -28.47, \"value\": 10853352}, {\"holder\": \"Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund\", \"shares\": 24533, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.05, \"pct_change\": -5.52, \"value\": 5299128}, {\"holder\": \"Northern Funds-SMALL CAP CORE FUND\", \"shares\": 13894, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.03, \"pct_change\": 0.0, \"value\": 3001104}, {\"holder\": \"EQ Advisors Trust-1290 VT Micro Cap Portfolio\", \"shares\": 9049, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.02, \"pct_change\": 0.0, \"value\": 1954584}]}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-09T02:31:35.034038\", \"ticker\": \"4875\", \"ticker_full\": \"4875.T\", \"company_name\": \"MEDICINOVA INC\", \"company_info\": {\"name_en\": \"MEDICINOVA INC\", \"long_name\": \"MediciNova, Inc.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/medicinova.com\", \"employees\": 6, \"country\": \"United States\", \"city\": \"La Jolla\", \"address\": \"4275 Executive Square\", \"description\": \"MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 209.6, \"deviation\": 0.19, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 217.8, \"deviation\": -3.58, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 216.64, \"deviation\": -3.06, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 226.13, \"deviation\": -7.14, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 409657.0, \"revenue_fmt\": \"\u00a5409,657\", \"gross_profit\": 31051.0, \"gross_profit_fmt\": \"\u00a531,051\", \"operating_income\": -13283002.0, \"operating_income_fmt\": \"-\u00a513.3M\", \"ebit\": -13283002.0, \"ebit_fmt\": \"-\u00a513.3M\", \"net_income\": -11997957.0, \"net_income_fmt\": \"-\u00a512.0M\", \"eps\": -0.24, \"operating_margin\": -3242.47, \"total_assets\": 45603109.0, \"total_assets_fmt\": \"\u00a545.6M\", \"total_equity\": 41586681.0, \"total_equity_fmt\": \"\u00a541.6M\", \"total_debt\": 194331.0, \"total_debt_fmt\": \"\u00a5194,331\", \"total_cash\": 30806477.0, \"total_cash_fmt\": \"\u00a530.8M\", \"equity_ratio\": 91.19, \"de_ratio\": 0.0, \"current_ratio\": 8.16, \"operating_cf\": -9810061.0, \"operating_cf_fmt\": \"-\u00a59.8M\", \"investing_cf\": -2899.0, \"investing_cf_fmt\": \"-\u00a52,899\", \"financing_cf\": 244018.0, \"financing_cf_fmt\": \"\u00a5244,018\", \"free_cf\": -9812960.0, \"free_cf_fmt\": \"-\u00a59.8M\", \"net_margin\": -2928.78, \"roe\": -28.85, \"roa\": -26.31}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0.0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -12675331.0, \"operating_income_fmt\": \"-\u00a512.7M\", \"ebit\": -12675331.0, \"ebit_fmt\": \"-\u00a512.7M\", \"net_income\": -11049549.0, \"net_income_fmt\": \"-\u00a511.0M\", \"eps\": -0.23, \"operating_margin\": 0, \"total_assets\": 55875926.0, \"total_assets_fmt\": \"\u00a555.9M\", \"total_equity\": 52503551.0, \"total_equity_fmt\": \"\u00a552.5M\", \"total_debt\": 193769.0, \"total_debt_fmt\": \"\u00a5193,769\", \"total_cash\": 40359738.0, \"total_cash_fmt\": \"\u00a540.4M\", \"equity_ratio\": 93.96, \"de_ratio\": 0.0, \"current_ratio\": 13.88, \"operating_cf\": -10642964.0, \"operating_cf_fmt\": \"-\u00a510.6M\", \"investing_cf\": -697.0, \"investing_cf_fmt\": \"-\u00a5697\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -10643859.0, \"free_cf_fmt\": \"-\u00a510.6M\", \"net_margin\": 0, \"roe\": -21.05, \"roa\": -19.78}, {\"year\": 2023, \"revenue\": 1000000.0, \"revenue_fmt\": \"\u00a51.0M\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -9900265.0, \"operating_income_fmt\": \"-\u00a59.9M\", \"ebit\": -9900265.0, \"ebit_fmt\": \"-\u00a59.9M\", \"net_income\": -8571516.0, \"net_income_fmt\": \"-\u00a58.6M\", \"eps\": -0.17, \"operating_margin\": -990.03, \"total_assets\": 66269977.0, \"total_assets_fmt\": \"\u00a566.3M\", \"total_equity\": 62378424.0, \"total_equity_fmt\": \"\u00a562.4M\", \"total_debt\": 215926.0, \"total_debt_fmt\": \"\u00a5215,926\", \"total_cash\": 50999442.0, \"total_cash_fmt\": \"\u00a551.0M\", \"equity_ratio\": 94.13, \"de_ratio\": 0.0, \"current_ratio\": 15.61, \"operating_cf\": -7431038.0, \"operating_cf_fmt\": \"-\u00a57.4M\", \"investing_cf\": 39907716.0, \"investing_cf_fmt\": \"\u00a539.9M\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -7452337.0, \"free_cf_fmt\": \"-\u00a57.5M\", \"net_margin\": -857.15, \"roe\": -13.74, \"roa\": -12.93}, {\"year\": 2022, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -14628649.0, \"operating_income_fmt\": \"-\u00a514.6M\", \"ebit\": -14628649.0, \"ebit_fmt\": \"-\u00a514.6M\", \"net_income\": -14069083.0, \"net_income_fmt\": \"-\u00a514.1M\", \"eps\": -0.29, \"operating_margin\": 0, \"total_assets\": 74154905.0, \"total_assets_fmt\": \"\u00a574.2M\", \"total_equity\": 70242035.0, \"total_equity_fmt\": \"\u00a570.2M\", \"total_debt\": 157505.0, \"total_debt_fmt\": \"\u00a5157,505\", \"total_cash\": 18505493.0, \"total_cash_fmt\": \"\u00a518.5M\", \"equity_ratio\": 94.72, \"de_ratio\": 0.0, \"current_ratio\": 18.51, \"operating_cf\": -12911563.0, \"operating_cf_fmt\": \"-\u00a512.9M\", \"investing_cf\": -40005010.0, \"investing_cf_fmt\": \"-\u00a540.0M\", \"financing_cf\": 7920.0, \"financing_cf_fmt\": \"\u00a57,920\", \"free_cf\": -12916573.0, \"free_cf_fmt\": \"-\u00a512.9M\", \"net_margin\": 0, \"roe\": -20.03, \"roa\": -18.97}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-58821","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MEDICINOVA INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4875\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4875\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4875\/\",\"name\":\"MEDICINOVA INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:16:54+00:00\",\"dateModified\":\"2026-08-09T05:01:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4875\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4875\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4875\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MEDICINOVA INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MEDICINOVA INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4875\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4875\/","url":"https:\/\/japanir.jp\/en\/company\/company-4875\/","name":"MEDICINOVA INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:16:54+00:00","dateModified":"2026-08-09T05:01:35+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4875\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4875\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4875\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"MEDICINOVA INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/58821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=58821"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=58821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}